Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jochen Reiser

Showing results (101-110 of 242) with videos related to

Pageof 25
Sort By:
Scientific Reports|January 28, 2014
In vivo imaging of kidney glomeruli transplanted into the anterior chamber of the mouse eyeAndreas D Kistler, Alejandro Caicedo, Midhat H Abdulreda, et al.
Pediatric Nephrology (Berlin, Germany)|November 23, 2013
CD80 and suPAR in patients with minimal change disease and focal segmental glomerulosclerosis: diagnostic and pathogenic significanceGabriel Cara-Fuentes, Changli Wei, Alfons Segarra, et al.
Journal of the American Society of Nephrology : JASN|July 20, 2001
Human immunodeficiency virus-1 induces loss of contact inhibition in podocytesElissa J Schwartz, Andrea Cara, Hans Snoeck, et al.
Journal of the American Heart Association|May 3, 2018
Predicting Mortality in African Americans With Type 2 Diabetes Mellitus: Soluble Urokinase Plasminogen Activator Receptor, Coronary Artery Calcium, and High-Sensitivity C-Reactive ProteinSalim S Hayek, Jasmin Divers, Mohamad Raad, et al.
Pediatric Nephrology (Berlin, Germany)|September 21, 2014
Case series: CTLA4-IgG1 therapy in minimal change disease and focal segmental glomerulosclerosisEduardo H Garin, Jochen Reiser, Gabriel Cara-Fuentes, et al.
Journal of Evaluation in Clinical Practice|October 14, 2022
Evaluation of a fast-and-frugal clinical decision algorithm ('pathways') on clinical outcomes in hospitalised patients with COVID-19 treated with anticoagulantsBenjamin Djulbegovic, Iztok Hozo, David Lizarraga, et al.
Scientific Reports|January 26, 2019
Soluble urokinase plasminogen activation receptor and long-term outcomes in persons undergoing coronary angiographyClaudia Sommerer, Martin Zeier, Christian Morath, et al.
Journal of the American Society of Nephrology : JASN|March 30, 2016
Synaptopodin Limits TRPC6 Podocyte Surface Expression and Attenuates ProteinuriaHao Yu, Andreas Kistler, Mohd Hafeez Faridi, et al.
Journal of Molecular Medicine (Berlin, Germany)|September 28, 2012
The calcineurin-NFAT pathway allows for urokinase receptor-mediated beta3 integrin signaling to cause podocyte injuryBin Zhang, Wei Shi, Juan Ma, et al.
Clinical Journal of the American Society of Nephrology : CJASN|February 24, 2022
Comparison of Aptamer-Based and Antibody-Based Assays for Protein Quantification in Chronic Kidney DiseaseCarolina Lopez-Silva, Aditya Surapaneni, Josef Coresh, et al.
Pageof 25

Showing results (101-110 of 242) with videos related to

Sort By:
Pageof 25
Scientific Reports|January 28, 2014
In vivo imaging of kidney glomeruli transplanted into the anterior chamber of the mouse eyeAndreas D Kistler, Alejandro Caicedo, Midhat H Abdulreda, et al.
Pediatric Nephrology (Berlin, Germany)|November 23, 2013
CD80 and suPAR in patients with minimal change disease and focal segmental glomerulosclerosis: diagnostic and pathogenic significanceGabriel Cara-Fuentes, Changli Wei, Alfons Segarra, et al.
Journal of the American Society of Nephrology : JASN|July 20, 2001
Human immunodeficiency virus-1 induces loss of contact inhibition in podocytesElissa J Schwartz, Andrea Cara, Hans Snoeck, et al.
Journal of the American Heart Association|May 3, 2018
Predicting Mortality in African Americans With Type 2 Diabetes Mellitus: Soluble Urokinase Plasminogen Activator Receptor, Coronary Artery Calcium, and High-Sensitivity C-Reactive ProteinSalim S Hayek, Jasmin Divers, Mohamad Raad, et al.
Pediatric Nephrology (Berlin, Germany)|September 21, 2014
Case series: CTLA4-IgG1 therapy in minimal change disease and focal segmental glomerulosclerosisEduardo H Garin, Jochen Reiser, Gabriel Cara-Fuentes, et al.
Journal of Evaluation in Clinical Practice|October 14, 2022
Evaluation of a fast-and-frugal clinical decision algorithm ('pathways') on clinical outcomes in hospitalised patients with COVID-19 treated with anticoagulantsBenjamin Djulbegovic, Iztok Hozo, David Lizarraga, et al.
Scientific Reports|January 26, 2019
Soluble urokinase plasminogen activation receptor and long-term outcomes in persons undergoing coronary angiographyClaudia Sommerer, Martin Zeier, Christian Morath, et al.
Journal of the American Society of Nephrology : JASN|March 30, 2016
Synaptopodin Limits TRPC6 Podocyte Surface Expression and Attenuates ProteinuriaHao Yu, Andreas Kistler, Mohd Hafeez Faridi, et al.
Journal of Molecular Medicine (Berlin, Germany)|September 28, 2012
The calcineurin-NFAT pathway allows for urokinase receptor-mediated beta3 integrin signaling to cause podocyte injuryBin Zhang, Wei Shi, Juan Ma, et al.
Clinical Journal of the American Society of Nephrology : CJASN|February 24, 2022
Comparison of Aptamer-Based and Antibody-Based Assays for Protein Quantification in Chronic Kidney DiseaseCarolina Lopez-Silva, Aditya Surapaneni, Josef Coresh, et al.
Pageof 25